TeleHealth | Tissuepathology.com

It’s Time to Re-Read Player Piano

Dr. Keith J. Kaplan — Thu, 22 May 2025 14:20:00 +0000

“The main business of humanity is to do a good job of being human beings,” said Paul, “not to serve as appendages to machines, institutions, and systems.” If you have not read Player Piano, it is a good read. I read it many years ago along with many other Vonnegut novels and listed to Player […]

The post It’s Time to Re-Read Player Piano first appeared on Tissuepathology.com.

Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine

Dr. Keith J. Kaplan — Wed, 19 Mar 2025 16:10:41 +0000

Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment Funding led by global software investor Insight Partners comes as the surge in cancer cases compounds the impact of the shrinking pathologist workforce The company will use the funds to grow […]

The post Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine first appeared on Tissuepathology.com.

DEA and HHS Extend Telemedicine Flexibilities through 2025

Dr. Keith J. Kaplan — Wed, 27 Nov 2024 20:16:07 +0000

DEA addressed the status of telemedicine prescribing flexibilities including state reciprocity (DEA-DC-018 EO-DEA067) and medications for opioid use disorder prescribed by telephone (DEA-DC-022 EO-DEA068) in the temporary rule titled “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” which published in the Federal Register on May 10, 2023. 88 FR 30042. With respect to […]

The post DEA and HHS Extend Telemedicine Flexibilities through 2025 first appeared on Tissuepathology.com.

Digital pathology is just pathology, but does it matter anymore?

Dr. Keith J. Kaplan — Tue, 16 Jan 2024 21:24:13 +0000

Since the 1990s, many innovators to Fortune 500 and Fortune 50 companies have worked to make digital pathology a reality. While not mainstream and perhaps less than 10% of US based pathology groups have any serious implementations of digital pathology, the technology has caught up to our retinas and the legal, regulatory, and business practices […]

The post Digital pathology is just pathology, but does it matter anymore? first appeared on Tissuepathology.com.

Andwin Scientific and Mikroscan Bring Leading Telemicroscopy Technology to Clinical Trials

Erica Goodpaster — Mon, 19 Sep 2022 11:38:02 +0000

Mikroscan: Clinical research supplier to offer telemicroscopy systems that improve pathology services in clinical trials September 1, 2021 (Simi Valley, CA) – Andwin Scientific, the leading provider of outsourced clinical research supply chain and laboratory supplies management to global life science organizations, announces that it has entered into a distribution agreement with Mikroscan Technologies, innovator and manufacturer of live […]

The post Andwin Scientific and Mikroscan Bring Leading Telemicroscopy Technology to Clinical Trials first appeared on Tissuepathology.com.

Recent Paper Discussing Potential Quality Pitfalls with WSI in Breast Cases

Dr. Keith J. Kaplan — Fri, 21 Jan 2022 15:31:27 +0000

Interesting paper recently published looking at potential quality issues in breast whole slide images across three scanners used. While it appears there may be tissue missing from an image due to faint staining and often times nearly translucent fatty tissue, the consequence of this seems to be of no diagnostic significance. Laboratories may want to […]

The post Recent Paper Discussing Potential Quality Pitfalls with WSI in Breast Cases first appeared on Tissuepathology.com.